ABUS 4Q19 results—12/31/19 pro forma cash=$103.1M—including $12.3M from use of ATM facility during 1Q20 to date: https://investor.arbutusbio.com/news-releases/news-release-details/arbutus-reports-fourth-quarter-and-year-end-2019-financial 2020 cash-burn guidance is $54-58M.